PLATT DAVID 4
4 · BIOXYTRAN, INC · Filed Jan 16, 2024
Insider Transaction Report
Form 4
BIOXYTRAN, INCBIXT
PLATT DAVID
DirectorCEO10% Owner
Transactions
- Award
common stock
2024-01-16$0.14/sh+3,599,289$485,904→ 19,693,423 total(indirect: by NDPD Pharma, Inc.)
Footnotes (1)
- [F1]The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.